Total Payments
$6,236
2024 Payments
$1,292
Companies
38
Transactions
358
Medicare Patients
3,619
Medicare Billing
$407,790
Payment Breakdown by Category
Food & Beverage$6,199 (99.4%)
Other$20.00 (0.3%)
Education$16.90 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,199 | 355 | 99.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $20.00 | 1 | 0.3% |
| Education | $16.90 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,683 | 78 | $0 (2024) |
| Janssen Biotech, Inc. | $714.50 | 47 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $616.61 | 43 | $0 (2024) |
| PFIZER INC. | $446.31 | 30 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $353.53 | 24 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $251.62 | 22 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $222.05 | 2 | $0 (2024) |
| QOL Medical, LLC | $186.36 | 13 | $0 (2024) |
| Intercept Pharmaceuticals, Inc. | $181.81 | 13 | $0 (2024) |
| Celgene Corporation | $127.12 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,292 | 69 | ABBVIE INC. ($237.84) |
| 2023 | $974.90 | 42 | ABBVIE INC. ($385.26) |
| 2022 | $527.42 | 30 | ABBVIE INC. ($282.59) |
| 2021 | $194.87 | 14 | AbbVie Inc. ($183.54) |
| 2020 | $628.74 | 30 | AbbVie Inc. ($241.83) |
| 2019 | $1,409 | 101 | AbbVie, Inc. ($295.02) |
| 2018 | $642.39 | 44 | BOSTON SCIENTIFIC CORPORATION ($97.18) |
| 2017 | $566.56 | 28 | Janssen Biotech, Inc. ($325.49) |
All Payment Transactions
358 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $20.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Immunology | ||||||
| 12/12/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Education | In-kind items and services | $8.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Immunology | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $15.55 | General |
| Category: THERAPY FOR CSID | ||||||
| 10/25/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.60 | General |
| Category: Rare Disease | ||||||
| 10/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: Immunology | ||||||
| 10/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Immunology | ||||||
| 10/07/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $17.19 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: Immunology | ||||||
| 09/24/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.51 | General |
| Category: LIVER DISEASE | ||||||
| 09/20/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Education | In-kind items and services | $8.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.96 | General |
| Category: Neuroscience | ||||||
| 09/12/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $97.05 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/30/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: INTERNAL MEDICINE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,015 | 1,157 | $960,501 | $117,306 |
| 2022 | 14 | 923 | 1,019 | $831,038 | $101,009 |
| 2021 | 11 | 881 | 1,033 | $784,582 | $102,295 |
| 2020 | 13 | 800 | 918 | $634,519 | $87,180 |
Total Patients
3,619
Total Services
4,127
Medicare Billing
$407,790
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 122 | 122 | $231,495 | $26,049 | 11.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 171 | 254 | $58,420 | $17,080 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 96 | 111 | $38,739 | $12,020 | 31.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 132 | 142 | $226,490 | $11,734 | 5.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 102 | 105 | $45,990 | $11,542 | 25.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 87 | 87 | $157,905 | $7,155 | 4.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 46 | 64 | $21,248 | $6,495 | 30.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 82 | 94 | $22,090 | $5,727 | 25.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $18,480 | $5,537 | 30.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $12,000 | $2,810 | 23.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 31 | 31 | $10,912 | $2,500 | 22.9% |
| 43255 | Control of bleeding of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 12 | 13 | $22,523 | $2,129 | 9.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $20,328 | $1,585 | 7.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $18,150 | $1,410 | 7.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 11 | 11 | $17,848 | $1,201 | 6.7% |
| 43273 | Exam of common bile and/or pancreatic duct using a flexible endoscope | Facility | 2023 | 11 | 11 | $32,450 | $1,101 | 3.4% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 11 | 11 | $3,575 | $733.15 | 20.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 13 | 13 | $1,859 | $495.50 | 26.7% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 112 | 117 | $222,008 | $24,380 | 11.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 124 | 150 | $35,250 | $11,070 | 31.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 131 | 138 | $220,110 | $10,418 | 4.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 125 | 160 | $36,800 | $9,486 | 25.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 55 | 55 | $34,211 | $9,089 | 26.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 68 | 72 | $31,536 | $7,666 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 58 | 66 | $23,034 | $6,339 | 27.5% |
About Dr. Eric Eschinger, MD
Dr. Eric Eschinger, MD is a Gastroenterology healthcare provider based in Toms River, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720184625.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Eschinger, MD has received a total of $6,236 in payments from pharmaceutical and medical device companies, with $1,292 received in 2024. These payments were reported across 358 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($6,199).
As a Medicare-enrolled provider, Eschinger has provided services to 3,619 Medicare beneficiaries, totaling 4,127 services with total Medicare billing of $407,790. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Toms River, NJ
- Active Since 09/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1720184625
Products in Payments
- STELARA (Biological) $787.25
- RINVOQ (Biological) $484.15
- XIFAXAN (Drug) $465.92
- XELJANZ (Drug) $394.27
- SKYRIZI (Biological) $323.27
- HUMIRA (Biological) $322.63
- ZEPOSIA (Drug) $240.22
- CLENPIQ (Drug) $219.35
- Humira (Biological) $182.96
- Entyvio (Biological) $180.09
- OCALIVA (Drug) $152.69
- TREMFYA (Drug) $149.30
- DUPIXENT (Biological) $138.76
- OMVOH (Drug) $125.57
- Cimzia (Drug) $112.93
- TRULANCE (Drug) $110.58
- LINZESS (Drug) $105.29
- AXIOS (Device) $97.18
- Sucraid (Drug) $95.49
- SUCRAID (Drug) $90.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Toms River
Mr. Neil Nagaria, Md, MD
Gastroenterology — Payments: $18,349
Gastroenterology $18,349
Teresa Tacopina, Md, MD
Gastroenterology — Payments: $7,735
Gastroenterology $7,735
Kenneth Glazier
Gastroenterology — Payments: $5,912
Gastroenterology $5,912
Carl Raso, Md, MD
Gastroenterology — Payments: $5,227
Gastroenterology $5,227
Gabrielle Corpuz, Pa-C, PA-C
Gastroenterology — Payments: $4,258
Gastroenterology $4,258
Jose Suatengco, Md, MD
Gastroenterology — Payments: $4,144
Gastroenterology $4,144